Literature DB >> 25465907

Quantitative measurement of heparin in comparison with conventional anticoagulation monitoring and the risk of thrombotic events in adults on extracorporeal membrane oxygenation.

David C Chu1, Abdel Ghanie Abu-Samra, Grayson L Baird, Cynthia Devers, Joseph Sweeney, Mitchell M Levy, Christopher S Muratore, Corey E Ventetuolo.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25465907      PMCID： PMC4576157          DOI： 10.1007/s00134-014-3574-3

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN： 0342-4642            Impact factor:   17.440


× No keyword cloud information.
  5 in total

1.  Anti-factor Xa assay is a superior correlate of heparin dose than activated partial thromboplastin time or activated clotting time in pediatric extracorporeal membrane oxygenation*.

Authors:  Anna Liveris; Ricardo A Bello; Patricia Friedmann; Melissa A Duffy; Deepa Manwani; James S Killinger; Daniel Rodriquez; Samuel Weinstein
Journal:  Pediatr Crit Care Med       Date:  2014-02       Impact factor: 3.624

Review 2.  Antifactor Xa levels versus activated partial thromboplastin time for monitoring unfractionated heparin.

Authors:  Jeremy W Vandiver; Thomas G Vondracek
Journal:  Pharmacotherapy       Date:  2012-04-24       Impact factor: 4.705

3.  Discordant aPTT and anti-Xa values and outcomes in hospitalized patients treated with intravenous unfractionated heparin.

Authors:  Elizabeth A Price; Jing Jin; Huong Marie Nguyen; Gomathi Krishnan; Raffick Bowen; James L Zehnder
Journal:  Ann Pharmacother       Date:  2013-02-05       Impact factor: 3.154

4.  Evaluation of the activated clotting time and activated partial thromboplastin time for the monitoring of heparin in adult extracorporeal membrane oxygenation patients.

Authors:  S Atallah; M Liebl; K Fitousis; F Bostan; F Masud
Journal:  Perfusion       Date:  2014-02-25       Impact factor: 1.972

5.  Unfractionated heparin activity measured by anti-factor Xa levels is associated with the need for extracorporeal membrane oxygenation circuit/membrane oxygenator change: a retrospective pediatric study.

Authors:  Katherine Irby; Christopher Swearingen; Jonathan Byrnes; Joshua Bryant; Parthak Prodhan; Richard Fiser
Journal:  Pediatr Crit Care Med       Date:  2014-05       Impact factor: 3.624
  5 in total
  6 in total

1.  Low-dose heparin during extracorporeal membrane oxygenation treatment in adults.

Authors:  Hye Ju Yeo; Do Hyung Kim; Doosoo Jeon; Yun Seong Kim; Woo Hyun Cho
Journal:  Intensive Care Med       Date:  2015-08-14       Impact factor: 17.440

2.  Focus on transfusion, bleeding and thrombosis.

Authors:  Elie Azoulay; Yaseen Arabi; Anders Perner
Journal:  Intensive Care Med       Date:  2016-10-25       Impact factor: 17.440

3.  Traditional and non-traditional anticoagulation management during extracorporeal membrane oxygenation.

Authors:  Andreas Koster; Edis Ljajikj; David Faraoni
Journal:  Ann Cardiothorac Surg       Date:  2019-01

4.  Reduced anticoagulation targets in extracorporeal life support (RATE): study protocol for a randomized controlled trial.

Authors:  Olivier van Minnen; Annemieke Oude Lansink-Hartgring; Bas van den Boogaard; Judith van den Brule; Pierre Bulpa; Jeroen J H Bunge; Thijs S R Delnoij; Carlos V Elzo Kraemer; Marijn Kuijpers; Bernard Lambermont; Jacinta J Maas; Jesse de Metz; Isabelle Michaux; Ineke van de Pol; Marcel van de Poll; S Jorinde Raasveld; Matthias Raes; Dinis Dos Reis Miranda; Erik Scholten; Olivier Simonet; Fabio S Taccone; Frederic Vallot; Alexander P J Vlaar; Walter M van den Bergh
Journal:  Trials       Date:  2022-05-16       Impact factor: 2.728

Review 5.  Venovenous extracorporeal membrane oxygenation for acute respiratory failure : A clinical review from an international group of experts.

Authors:  Eddy Fan; Luciano Gattinoni; Alain Combes; Matthieu Schmidt; Giles Peek; Dan Brodie; Thomas Muller; Andrea Morelli; V Marco Ranieri; Antonio Pesenti; Laurent Brochard; Carol Hodgson; Cecile Van Kiersbilck; Antoine Roch; Michael Quintel; Laurent Papazian
Journal:  Intensive Care Med       Date:  2016-03-23       Impact factor: 17.440

6.  Machine learning to predict hemorrhage and thrombosis during extracorporeal membrane oxygenation.

Authors:  Adeel Abbasi; Yasmin Karasu; Cindy Li; Neel R Sodha; Carsten Eickhoff; Corey E Ventetuolo
Journal:  Crit Care       Date:  2020-12-10       Impact factor: 9.097
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.